版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、自身免疫性炎癥綜合癥自身免疫性炎癥綜合癥2自身免疫性炎癥綜合癥2自身免疫性炎癥綜合癥3自身免疫性炎癥綜合癥3自身免疫性炎癥綜合癥Autoinflammatory - 1999“ The autosomal dominantperiodic feverstherefore represent a class ofhumandisease shown to be caused by mutations inTNFreceptors. Autoantibodies are not a general feature of these illnesses or the recessively inhe
2、ritedFMF, and for this reason the termautoinflammatoryis preferable to autoimmunein describing these disorders.”“Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.” McDermott, et al., Cell.1999 Apr 2;
3、97(1):133-44.4自身免疫性炎癥綜合癥Autoinflammatory - 1999“ The“Autoinflammatory” DiseaseAt the time, autoinflammatory was coined to distinguish diseases involving innate immune dysregulation (FMF & TRAPS) from autoimmune diseases known to involve adaptive immune dysregulation (SLE & RA).Two premises of autoim
4、mune disease are unfulfilled in autoinflammatory disorders:The inflammation is seemingly “unprovoked”.Autoantibodies and antigen-specific T cells are absent.5自身免疫性炎癥綜合癥“Autoinflammatory” DiseaseAt t6自身免疫性炎癥綜合癥6自身免疫性炎癥綜合癥7自身免疫性炎癥綜合癥7自身免疫性炎癥綜合癥8自身免疫性炎癥綜合癥8自身免疫性炎癥綜合癥9自身免疫性炎癥綜合癥9自身免疫性炎癥綜合癥CytokineDiseas
5、e GeneProteinInherit. patternDisease onsetFever patternSpecific organ inflammationIL-1bCAPSFCASMWSCIAS1CIAS1CIAS1CryopyrinCryopyrinCryopyrinADADAD6 m, cold induced Infancy adolescenceNeonatal or early infancy24h24-48hContinuous with flaresSkin, eyes, joints,systemicSkin, eyes, joints, inner ears, me
6、ninges (mild),systemicSkin, eyes, joints, inner ears, meningges, bony epiphyseal hyperplasia,systemicIL-1b and IL-1aDIRAIL-1RNIL-1RaARNeonatal or early infancyContinuous with flaresskin, bones, lungs, vasculitisIL-1FCASNLRP12NLRP12ADNeonatal or early infancyContinous with flaresSkin, eyes, joints,Sy
7、stemicIL-1FMFMEFVPyrinAR80% 20yo1-3 daysSkin, joints, peritoneum, pleuraIL-1HIDSMVKMevalonate kinaseAR 6 months3-7 daysSkin, eyes, joints, prominent lymph nodesIL-1Majeeds syndromeLPIN2lipin2AR1-19 mWeeks-monthsBones, periosteum, anemiaIL-1 + TNFIL-1 + TNFTRAPSPAPATNFRSF1ACD2BP1TNFR1PSTPIP1ADAD3 yea
8、rsEarly childhood1-4 weeksCommonSkin, eyes, joints, peritoneum, pleuraSkin, jointsAID IL-1 PathwayGoldbach-Monsky, Clin Exp Immunol, 2011, 167:391-40410自身免疫性炎癥綜合癥CytokineDisease GeneProteinInhPro-IL-1bIL-1bInactiveactiveNLRP3 and IL-1Schroder and Tschopp, Cell, 2010, 140:821-82311自身免疫性炎癥綜合癥Pro-IL-1b
9、IL-1bInactiveactiveNLGoldbach-Mansky, Clin Exp Immunol, 2012, 167:391-404Activation of Inflammasome12自身免疫性炎癥綜合癥Goldbach-Mansky, Clin Exp Immu13自身免疫性炎癥綜合癥13自身免疫性炎癥綜合癥編碼不同蛋白的基因突變14自身免疫性炎癥綜合癥編碼不同蛋白的基因突變14自身免疫性炎癥綜合癥CytokineDisease GeneProteinInherit. patternDisease onsetFever patternSpecific organ infla
10、mmationTNF, IL-1PGANOD2nod2ADEarly childhooduncommonSkin, eyes, jointsTNFCherubismSH3BP2SH3BP2ADChildhood, spontaneous ression by 3rd decadeUncommonjaws, eyes Lack of IL-10 signallingEarly onset IBDIL10RAIL-10R, IL10RB also forms IL-12-26, 28, 29 RARNeonatal or early infancyContinuous with flaresCol
11、itis with fistula formation, folliculitis in patients with IL-10RB mutationsIL-36a, IL-36b, IL-36g DITRAIL10RB,IL-36RN/IL-1F5IL-36ARCarriable to adulthood, Flares of generalized and palmoplantar pustulosisSkin Increase in IFN signallingJMP, NNS, JASL, CANDLEPSMB8Inducible b5 subunit of immuno-protea
12、someAR Neonatal or early infancyContinuous with flaresSkin, joints, lipodystrophy and muscle atrophyAID other Cytokine PathwaysGoldbach-Monsky, Clin Exp Immunol, 2011, 167:391-40415自身免疫性炎癥綜合癥CytokineDisease GeneProteinInh隱熱蛋白相關(guān)周期綜合征16自身免疫性炎癥綜合癥隱熱蛋白相關(guān)周期綜合征16自身免疫性炎癥綜合癥17自身免疫性炎癥綜合癥17自身免疫性炎癥綜合癥Cryopyrin
13、相關(guān)周期綜合征(CAPS)炎性刺激含有cryopyrin的炎癥小體活化(CAPS)半胱天東酶1活化(IL-1轉(zhuǎn)化酶)產(chǎn)生IL-1炎癥免疫細(xì)胞活化凋亡和組織損傷炎癥小體pyrin類異戊二烯代謝 突變cryopyrin作用:尚未完全闡明降低炎癥活化的閾值,使炎癥觸發(fā)更加敏感炎癥的啟動(dòng)正常,但炎癥的關(guān)閉被干擾18自身免疫性炎癥綜合癥Cryopyrin相關(guān)周期綜合征(CAPS)炎性刺激含有cr19自身免疫性炎癥綜合癥19自身免疫性炎癥綜合癥CAPS臨床分型和疾病譜輕度表型中度表型重度表型FCAS 寒冷誘發(fā)的蕁麻疹 發(fā)熱 關(guān)節(jié)痛MWS 蕁麻疹 低熱 關(guān)節(jié)炎 淀粉樣變 耳聾NOMID 新生兒起病的蕁麻疹
14、發(fā)熱 關(guān)節(jié)病,可變形 淀粉樣變 中樞神經(jīng)系統(tǒng)表現(xiàn)腦膜炎視力障礙20自身免疫性炎癥綜合癥CAPS臨床分型和疾病譜輕度表型中度表型重度表型FCASMWNLRP3炎性體基因突變21自身免疫性炎癥綜合癥NLRP3炎性體基因突變21自身免疫性炎癥綜合癥22自身免疫性炎癥綜合癥22自身免疫性炎癥綜合癥23自身免疫性炎癥綜合癥23自身免疫性炎癥綜合癥24自身免疫性炎癥綜合癥24自身免疫性炎癥綜合癥25自身免疫性炎癥綜合癥25自身免疫性炎癥綜合癥26自身免疫性炎癥綜合癥26自身免疫性炎癥綜合癥27自身免疫性炎癥綜合癥27自身免疫性炎癥綜合癥IL-1阻滯劑治療CAPS炎性刺激含有隱熱蛋白的炎癥小體活化半胱天東酶
15、1活化(IL-1轉(zhuǎn)化酶)產(chǎn)生IL-1炎癥免疫細(xì)胞活化組織損傷炎癥小體IL-1阻滯劑 Anakinra:IL-1ra拮抗劑 Canakinumab:IL-1單抗 Rilonacept:IL-1Trap28自身免疫性炎癥綜合癥IL-1阻滯劑治療CAPS炎性刺激含有隱熱蛋白的炎癥小體活化29自身免疫性炎癥綜合癥29自身免疫性炎癥綜合癥家族性地中海熱(FMF)含有cryopyrin的炎癥小體活化炎性刺激半胱天東酶1活化(IL-1轉(zhuǎn)化酶)產(chǎn)生IL-1炎癥免疫細(xì)胞活化凋亡和組織損傷pyrin(FMF)炎癥小體30自身免疫性炎癥綜合癥家族性地中海熱(FMF)含有cryopyrin的炎癥小體活化31自身免疫性
16、炎癥綜合癥31自身免疫性炎癥綜合癥治療:NSAIDs:秋水仙堿:減緩WBC趨化和炎性因子產(chǎn)生,預(yù)防淀粉樣變神經(jīng)病變IL-1拮抗劑預(yù)后:1個(gè)基因突變:治療反應(yīng)良好H478Y MEFV variant:秋水仙堿無(wú)效M694V突變:易淀粉樣變32自身免疫性炎癥綜合癥治療:32自身免疫性炎癥綜合癥激素有效(3-5天),秋水仙堿無(wú)效TNFa拮抗劑和IL-1拮抗劑部分有效33自身免疫性炎癥綜合癥激素有效(3-5天),秋水仙堿無(wú)效33自身免疫性炎癥綜合癥MKD(高IgD綜合征,HIDS)炎性刺激含有cryopyrin的炎癥小體活化(CAPS)半胱天東酶1活化(IL-1轉(zhuǎn)化酶)產(chǎn)生IL-1炎癥免疫細(xì)胞活化凋亡
17、和組織損傷炎癥小體pyrin類異戊二烯代謝MVK(甲羥戊酸激酶)(HIDS)34自身免疫性炎癥綜合癥MKD(高IgD綜合征,HIDS)炎性刺激含有cryopyr35自身免疫性炎癥綜合癥35自身免疫性炎癥綜合癥36自身免疫性炎癥綜合癥36自身免疫性炎癥綜合癥37自身免疫性炎癥綜合癥37自身免疫性炎癥綜合癥腫瘤壞死因子受體相關(guān)周期綜合征(TRAPS)38自身免疫性炎癥綜合癥腫瘤壞死因子受體相關(guān)周期綜合征(TRAPS)38自身免疫性炎39自身免疫性炎癥綜合癥39自身免疫性炎癥綜合癥40自身免疫性炎癥綜合癥40自身免疫性炎癥綜合癥PAPA綜合征炎性刺激含有cryopyrin的炎癥小體活化半胱天東酶1活
18、化(IL-1轉(zhuǎn)化酶)產(chǎn)生IL-1炎癥免疫細(xì)胞活化凋亡和組織損傷炎癥小體pyrin類異戊二烯代謝 PSPSTPIP1(PAPA)41自身免疫性炎癥綜合癥PAPA綜合征炎性刺激含有cryopyrin的炎癥小體活化半42自身免疫性炎癥綜合癥42自身免疫性炎癥綜合癥43自身免疫性炎癥綜合癥43自身免疫性炎癥綜合癥自身免疫性炎癥綜合癥培訓(xùn)課件45自身免疫性炎癥綜合癥45自身免疫性炎癥綜合癥46自身免疫性炎癥綜合癥46自身免疫性炎癥綜合癥47自身免疫性炎癥綜合癥47自身免疫性炎癥綜合癥Schnitzlers syndrome 200 cases reported world wide de Koning
19、et al, 2007, Semin Arthritis Rheum48自身免疫性炎癥綜合癥Schnitzlers syndrome 200 c49自身免疫性炎癥綜合癥49自身免疫性炎癥綜合癥50自身免疫性炎癥綜合癥50自身免疫性炎癥綜合癥Schnitzler SyndromeDifferential Diagnosis51自身免疫性炎癥綜合癥Schnitzler SyndromeDifferentiaNOD2 Associated Autoinflammatory DiseasesNOD2 gene: R702W and IVS8 +158Yao et al, 2013, J Am Acad
20、 Dermatol, 68:624-3152自身免疫性炎癥綜合癥NOD2 Associated Autoinflammato53自身免疫性炎癥綜合癥53自身免疫性炎癥綜合癥Table1.Underlying mechanisms and causes of chronic urticarial rashMast cell mediatormediatedInterleukin-1-mediatedaaInterleukin-1 may also be, at least in part, mast cell-derived.Chronic spontaneous urticaria (CSU)
21、Cryopyrin-associated periodic syndrome (CAPS)CSU due to autoreactivitySchnitzlers syndrome (SchS)Other autoinflammatory disorders:NLRP12-associated cold-induced autoinflammatory syndrome (FCAS2)CSU due to functional autoantibodiesSystemic-onset juvenile idiopathic arthritis (soJIA)Adult-onset Stills
22、 disease (AOSD)Mevalonate kinase deficiency (MKD)TNF-receptor-associated periodic syndrome (TRAPS)54自身免疫性炎癥綜合癥Table1.Underlying mechanismsTable3.Clinical signs and symptoms of selected autoinflammatory diseases and possible differential diagnosesClinical signs and symptomsAutoinflammatory disorderDi
23、fferential diagnosisCAPSSchnitzlers syndromeNLRP12-associated FCASsoJIAAOSDMKDTRAPSThe clinical signs and symptoms represent a selection of common features and are found in other nonurticarial autoinflammatory diseases such as familial Mediterranean fever (FMF), periodic fever, aphthous stomatitis,
24、pharyngitis and adenitis syndrome (PFAPA), Behcets disease and others as well.Chronic urticarial rashXXXXXXXUrticaria (spontaneous or induced, e.g. cold contact urticaria)Urticarial vasculitisEye redness and painXXAllergic conjunctivitisUveitis (autoimmune, infectious)Periorbital oedemaXAngioedemaAl
25、lergic contact dermatitisSerositisXAutoimmune connective tissue disorderStomatitis, aphthaeXAllergyAutoimmune disorderInfectionAbdominal pain, diarrhoeaXXFood allergyInflammatory bowel diseaseProteinuriaXXXAutoimmune connective tissue disorderLymphadenopathyXXXXXXXInfectionMalignancyAutoimmune conne
26、ctive tissue disorderMyalgiaXXXXInfectionAutoimmune connective tissue disorderArthralgia/arthritisXXXXXXXRheumatoid arthritisJIAReactive arthritisAutoimmune connective tissue disorderHeadache and other CNS symptomsXXXMigraineFeverXXXXXXXInfectionMalignancyImmunodeficiencyAutoimmune connective tissue
27、 disorder55自身免疫性炎癥綜合癥Table3.Clinical signs and syTable4.Distinguishing criteria of chronic urticaria and autoinflammatory syndromesCharacteristics of urticarial rashChronic urticariaAutoinflammatory syndromeAppearancePapular whealsWheal-and-flare reactionFlatter wheals, erythematous patches but also more solid and stable lesionsNo wheal with surrounding flareLocalizationAsymmetrical distribution commonRather symmet
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年江西現(xiàn)代職業(yè)技術(shù)學(xué)院高職單招職業(yè)技能測(cè)試近5年??及鎱⒖碱}庫(kù)含答案解析
- 2025年梅河口康美職業(yè)技術(shù)學(xué)院高職單招高職單招英語(yǔ)2016-2024歷年頻考點(diǎn)試題含答案解析
- 2025年昆明衛(wèi)生職業(yè)學(xué)院高職單招語(yǔ)文2018-2024歷年參考題庫(kù)頻考點(diǎn)含答案解析
- 2025年注冊(cè)城鄉(xiāng)規(guī)劃師《城鄉(xiāng)規(guī)劃原理》真題及答案
- 幼兒園祖國(guó)主題活動(dòng)策劃方案模板五篇
- 零件買賣合同協(xié)議書
- 未來(lái)養(yǎng)老行業(yè)面臨的挑戰(zhàn)與機(jī)遇
- 全球民用航空運(yùn)輸市場(chǎng)現(xiàn)狀分析
- 物品運(yùn)輸合同協(xié)議書
- 建設(shè)工程基本建設(shè)貸款合同
- 2025福建新華發(fā)行(集團(tuán))限責(zé)任公司校園招聘30人高頻重點(diǎn)提升(共500題)附帶答案詳解
- 山東鐵投集團(tuán)招聘筆試沖刺題2025
- 圖像敘事的跨學(xué)科視野-洞察分析
- 2025年中考英語(yǔ)總復(fù)習(xí):閱讀理解練習(xí)題30篇(含答案解析)
- 陜西省英語(yǔ)中考試卷與參考答案(2024年)
- 基于OBE理念的世界現(xiàn)代史教學(xué)與學(xué)生歷史思維培養(yǎng)探究
- 施工現(xiàn)場(chǎng)揚(yáng)塵污染治理巡查記錄
- 2024年列車員技能競(jìng)賽理論考試題庫(kù)500題(含答案)
- 中南大學(xué)《藥理學(xué)》2023-2024學(xué)年第一學(xué)期期末試卷
- 《無(wú)人機(jī)測(cè)繪技術(shù)》項(xiàng)目3任務(wù)2無(wú)人機(jī)正射影像數(shù)據(jù)處理
- 《ISO 55013-2024 資產(chǎn)管理-數(shù)據(jù)資產(chǎn)管理指南》專業(yè)解讀和應(yīng)用指導(dǎo)材料(雷澤佳編制-2024B0)-121-240
評(píng)論
0/150
提交評(píng)論